231 related articles for article (PubMed ID: 21622723)
41. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
42. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
43. DNA damage repair pathways in cancer stem cells.
Maugeri-Saccà M; Bartucci M; De Maria R
Mol Cancer Ther; 2012 Aug; 11(8):1627-36. PubMed ID: 22844074
[TBL] [Abstract][Full Text] [Related]
44. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
Borst P
Open Biol; 2012 May; 2(5):120066. PubMed ID: 22724067
[TBL] [Abstract][Full Text] [Related]
45. [Cancer stem cells and chemotherapy].
Gligorov J; Benderra MA; Zaoui M; Sabbah M; Larsen A
Bull Cancer; 2017 Dec; 104(12):1085-1087. PubMed ID: 29162224
[No Abstract] [Full Text] [Related]
46. [Tumor stem cells and drug resistance].
Ou Y; Guo XL
Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):115-9. PubMed ID: 17633223
[TBL] [Abstract][Full Text] [Related]
47. Cancer stem cells: A brief review of the current status.
Kuşoğlu A; Biray Avcı Ç
Gene; 2019 Jan; 681():80-85. PubMed ID: 30268439
[TBL] [Abstract][Full Text] [Related]
48. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.
Dauer P; Nomura A; Saluja A; Banerjee S
Pancreatology; 2017; 17(1):7-12. PubMed ID: 28034553
[TBL] [Abstract][Full Text] [Related]
49. Tumour stem cells and drug resistance.
Dean M; Fojo T; Bates S
Nat Rev Cancer; 2005 Apr; 5(4):275-84. PubMed ID: 15803154
[TBL] [Abstract][Full Text] [Related]
50. Stem cell quiescence.
Li L; Bhatia R
Clin Cancer Res; 2011 Aug; 17(15):4936-41. PubMed ID: 21593194
[TBL] [Abstract][Full Text] [Related]
51. An outline of main factors of drug resistance influencing cancer therapy.
Frączek N; Bronisz I; Pietryka M; Kępińska D; Strzała P; Mielnicka K; Korga A; Dudka J
J Chemother; 2016 Dec; 28(6):457-464. PubMed ID: 27545330
[TBL] [Abstract][Full Text] [Related]
52. Mitochondria-centric bioenergetic characteristics in cancer stem-like cells.
Shin MK; Cheong JH
Arch Pharm Res; 2019 Feb; 42(2):113-127. PubMed ID: 30771209
[TBL] [Abstract][Full Text] [Related]
53. Tumor microenvironment-mediated chemoresistance in breast cancer.
Velaei K; Samadi N; Barazvan B; Soleimani Rad J
Breast; 2016 Dec; 30():92-100. PubMed ID: 27668856
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
Roesch A; Paschen A; Landsberg J; Helfrich I; Becker JC; Schadendorf D
Eur J Cancer; 2016 May; 59():109-112. PubMed ID: 27023049
[TBL] [Abstract][Full Text] [Related]
55. Decoding Novel Mechanisms and Emerging Therapeutic Strategies in Breast Cancer Resistance.
Shafi S; Khan S; Hoda F; Fayaz F; Singh A; Khan MA; Ali R; Pottoo FH; Tariq S; Najmi AK
Curr Drug Metab; 2020; 21(3):199-210. PubMed ID: 32124694
[TBL] [Abstract][Full Text] [Related]
56. Fighting Cancer Resistance: An Overview.
Robles-Flores M
Methods Mol Biol; 2021; 2174():3-12. PubMed ID: 32813240
[TBL] [Abstract][Full Text] [Related]
57. Transcriptomic study of dormant gastrointestinal cancer stem cells.
Nishikawa S; Dewi DL; Ishii H; Konno M; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Noguchi Y; Ozaki M; Sakai D; Satoh T; Doki Y; Mori M
Int J Oncol; 2012 Sep; 41(3):979-84. PubMed ID: 22735680
[TBL] [Abstract][Full Text] [Related]
58. Leukemia stem cells and new strategies to overcome resistance to therapy.
Thomas X; Cannas G
Curr Stem Cell Res Ther; 2010 Sep; 5(3):277-86. PubMed ID: 20528758
[TBL] [Abstract][Full Text] [Related]
59. Molecular aspects of cancer cell resistance to chemotherapy.
Rebucci M; Michiels C
Biochem Pharmacol; 2013 May; 85(9):1219-26. PubMed ID: 23435357
[TBL] [Abstract][Full Text] [Related]
60. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
Gaggianesi M; Di Franco S; Pantina VD; Porcelli G; D'Accardo C; Verona F; Veschi V; Colarossi L; Faldetta N; Pistone G; Bongiorno MR; Todaro M; Stassi G
Front Oncol; 2021; 11():702642. PubMed ID: 34354950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
